Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 11 EP applications Sarah Louise Thompson has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after December 09, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP13195495

Complexes of IL-15 and IL-15R alpha and uses thereof

IPC classification:
A61K 39/395
Applicant:
Novartis AG
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Sarah Louise Thompson, Novartis Pharma AG
Agent:
Jones Day
Status:
GRANT OF PATENT INTENDED
EP13195499

Complexes of IL-15 and IL-15R alpha and uses thereof

IPC classification:
A61K 39/395, C07K 16/00
Applicant:
Novartis AG
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Sarah Louise Thompson, Novartis Pharma AG
Agent:
Jones Day
Status:
GRANT OF PATENT INTENDED
EP15706583

IMPACT OF GENETIC FACTORS ON DISEASE PROGRESSION AND RESPONSE TO ANTI-C5 ANTIBODY IN GEOGRAPHIC ATROPHY

IPC classification:
C12Q 1/68
Applicant:
Novartis AG
Agent:
Sarah Louise Thompson, Novartis Pharma AG
Status:
EXAMINATION REQUESTED
EP16174632

USE OF IL-15-IL-15 RECEPTOR HETERODIMERS TO TREAT LYMPHOPENIA

IPC classification:
A61K 38/17, C07K 14/715, C07K 14/54, A61K 45/06, A61P 37/04, A61K 48/00, A61K 47/50, A61K 38/20
Agent:
Sarah Louise Thompson, Novartis Pharma AG
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
Request for examination was made
EP15828027

IL-15 AND IL-15RALPHA HETERODIMER DOSE ESCALATION REGIMENS FOR TREATING CONDITIONS

IPC classification:
A61K 48/00, A61K 38/20, A61P 31/18, A61P 37/04, C12N 5/0783
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Applicant:
Novartis AG
Agent:
Sarah Louise Thompson, Novartis Pharma AG
Status:
Request for examination was made
EP15784870

COMPOSITIONS AND METHODS OF USE FOR AUGMENTED IMMUNE RESPONSE AND CANCER THERAPY

IPC classification:
A61K 39/00, C07K 16/28
Applicant:
Novartis AG
Agent:
Sarah Louise Thompson, Novartis Pharma AG
Status:
Request for examination was made
EP15795063

COMPOSITIONS AND METHODS OF USE FOR AUGMENTED IMMUNE RESPONSE AND CANCER THERAPY

IPC classification:
A61K 39/00, C07K 16/28
Applicant:
Novartis AG
Agent:
Sarah Louise Thompson, Novartis Pharma AG
Status:
Request for examination was made
EP17182599

COMPOSITIONS AND METHODS FOR IMMUNOMODULATION IN AN ORGANISM

IPC classification:
C12P 21/04, C07K 16/00, C07K 1/00
Applicant:
University of Connecticut
Agent:
Sarah Louise Thompson, Novartis Pharma AG
Status:
The application has been published
EP16790722

ANTIBODY CONJUGATES COMPRISING TOLL-LIKE RECEPTOR AGONIST

IPC classification:
A61P 35/00, C07D 473/34, A61K 31/52, A61K 47/68
Applicant:
Novartis AG
Agent:
Sarah Louise Thompson, Novartis Pharma AG
Status:
Request for examination was made
EP16810069

ANTIBODY CYTOKINE ENGRAFTED COMPOSITIONS AND METHODS OF USE FOR IMMUNOREGULATION

IPC classification:
C07K 14/54
Applicant:
Novartis AG
Agent:
Sarah Louise Thompson, Novartis Pharma AG
Status:
Request for examination was made
EP16822542

ANTIBODIES TARGETING CD32B AND METHODS OF USE THEREOF

IPC classification:
C07K 16/28, A61K 39/395
Applicant:
Novartis AG
Agent:
Sarah Louise Thompson, Novartis Pharma AG
Status:
Request for examination was made

Please Sign in to use this feature